Discover the challenges in macrocycle R&D affecting biologics uptake and their implications for patient treatment.

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced the successful closing of a ...

A new startup is revolutionizing how textile and plastic waste are recycled, cutting costs and improving efficiency. MacroCycle has developed a way to convert plastic and textile waste into polyester ...

Allschwil, Switzerland, July 31, 2013 - Polyphor, a research-driven pharmaceutical company and leader in the discovery and development of macrocyclic drugs, today announced that Boehringer Ingelheim ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for difficult-to-treat cancers ...

Macrocycles are difficult to synthesize because there’s an entropic penalty associated with the ring closure. Chemists have multiple approaches to overcome that penalty and make the rings, each with ...

In fact, more than 60 peptide-based therapies and macrocycle drug molecules have been approved till date, across the globe. In addition, more than 400 peptide based drugs are currently being evaluated ...

Have updates? Send them our way! You know your company best! If there is information about your company that you’d like changed, please fill out the linked form to submit an update.

Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for difficult-to-treat cancers, today announced an agreement with Eli Lilly ...